XBIT

XBiotech Inc.

Price

$2.20

return (12m)

-19.12%

p/e

-1.48

p/bv

0.52

DIVIDEND YIELD

0.00%

XBIT price

XBiotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XBIT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.17%

3 months

-7.17%

1 year

-19.12%

2 years

-68.84%

5 years

-86.32%

10 years

-83.47%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals XBIT

Valuation

P/E

-1.48

Sector -3.53

Industry -3.53

P/BV

0.52

Sector 2.06

Industry 2.06

P/Revenue (PSR)

Sector 2.02

Industry 2.02

EV/EBITDA

6.70

Sector -222.67

Industry -222.67

EV/EBIT

6.40

Sector -47.57

Industry -47.57

P/EBITDA

-1.54

Sector -21.45

Industry -21.45

P/EBIT

-1.49

Sector -28.49

Industry -28.49

P/Total Assets

0.50

Sector 1.20

Industry 1.20

P/Net Current Assets

0.63

Sector -10.32

Industry -10.32

P/Working Capital

0.62

Sector -169.93

Industry -169.93

EPS

-1.48

Sector -1.79

Industry -1.79

BVPS

4.21

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-35.13%

Sector -56.67%

Industry -56.67%

ROA

-33.77%

Sector -59.91%

Industry -59.91%

ROIC

-108.59%

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

33.15

Sector 2.88

Industry 2.88

Net Debt / EBITDA

17.17

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

16.39

Sector -8.02

Industry -8.02

Net Debt / Equity

-0.85

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

0.96

Sector 0.46

Industry 0.46

Liabilities/Assets

0.04

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

20.98%

Sector -

Industry -

Fundamentals XBIT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XBIT XBiotech Inc.	$2.20	-19.12%	0.00%	-1.48	0.52	-35.13%	0.00%
JNJ Johnson & Johnson	$267.99	54.49%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.60	23.23%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.80	25.09%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.06	-22.81%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$144.27	85.01%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.87	7.46%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$64.10	44.86%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.75	-48.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$377.96	41.54%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$777.64	35.76%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.82	41.25%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$891.74	27.52%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$516.44	31.34%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$234.32	57.92%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$983.51	29.95%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$42.97	32.22%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XBIT Historical Dividends

current DY: 0.00%

5-year average DY: 4.46%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/14/2021	07/23/2021	2.50000000

ABOUT XBiotech

XBiotech Inc.

Average Investor10 user rating

4.0 (1 people)

United States

21 years

Founded: 2005

2015

Time since IPO - 11 years

87

Employees

XBiotech Inc. (United States) is listed on the Nasdaq and has a market capitalization of $66.77 million, with shareholders equity totaling $128.46 million.

The company employs approximately 87 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, XBiotech Inc. reported $- in revenue, generating net income of $-45.13 million.

Key financial metrics include a P/E ratio of -1.48, a price-to-book (P/B) ratio of 0.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XBIT.

Market cap

$66.77 million

Net worth

$128.46 million

$128,461,000.00

Assets

$133.65 million

$133,651,000.00

Total Shares Outstanding

30.49 million

30,487,000

Average Daily Trading Volume

$43.33 Thousand

$43,329.22

Sector

Health Care

Industry

Biotechnology

XBIT

XBIT revenue and profits

Financial Results XBIT

DRAG THE FRAME TO SEE MORE DATA

XBIT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$891.74 29,25% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$234.32 59,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$267.99 55,31% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.80 25,88% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$144.27 84,85% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.87 7,28% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.60 23,59% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$891.74 29,25% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$234.32 59,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$267.99 55,31% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.80 25,88% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$144.27 84,85% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.87 7,28% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.60 23,59% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of XBiotech (XBIT) today?

A cotação de XBiotech (XBIT) hoje está em US$ 2.20, com uma variação de -19.12% em relação ao último ano. A cotação de XBiotech (XBIT) iniciou o ano negociando na casa dos US$ 2.39 e hoje está em US$ 2.20. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de XBiotech (XBIT) e dados de ações do Ibovespa e mercados internacionais.

Quando XBiotech (XBIT) paga dividendos?

XBiotech (XBIT) não distribuiu dividendos no último ano.

Is XBiotech (XBIT) a good investment?

Atualmente, XBiotech (XBIT) está cotada a US$ 2.20, com um P/L de -1.48, representando um desvio de -291% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -19.12 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -19.12%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy XBiotech (XBIT) stock?

Investir em ações de XBiotech (XBIT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of XBiotech (XBIT) yield today?

A rentabilidade de XBiotech (XBIT) foi de -5.17% no último mês, -19.12% no último ano e -86.32% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de XBiotech (XBIT) hoje, o investimento total seria de US$ 220.00, com base na cotação atual de US$ 2.20.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 177.94
Em 5 anos: US$ 30.10
Em 10 anos: US$ 36.37

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XBIT

XBiotech Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XBIT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XBIT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 4.46%

type

Ex - Dividend Date

payment date

value

ABOUT XBiotech

XBiotech Inc.

United States

21 years

2015

87

PROFIT X PRICE XBIT

Financial Results XBIT

XBIT cash flow

Asset, Revenue and Profit Growth - XBIT

XBIT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions